跳至主要内容
临床试验/NCT04694638
NCT04694638已完成不适用

The Use of Combined Prone Positioning and High-Flow Nasal Cannula, and Non-invasive Positive Pressure Ventilation to Prevent Intubation in Acute Hypoxemic and/or Hypercapnic Respiratory Failure Secondary to COVID-19 Infection: A Feasibility, Safety Phase One, Open Label Study

Mayo Clinic1 个研究点 分布在 1 个国家目标入组 6 人开始时间: 2020年5月21日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
Mayo Clinic
入组人数
6
试验地点
1
主要终点
Rate of intubation

研究概览

简要总结

This research aims to understand if prone positioning combined with high-flow nasal cannula (HFNC) or non-invasive positive pressure ventilation (NIPPV) safely reduce the rate of intubation in acute hypoxemic and/or hypercapnic respiratory failure secondary to COVID-19 infection.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 110 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patients with confirmed COVID19 infection or suspected COVID19 infection.
  • •Patients requiring HFNC or NIPPV
  • •Patients who are clinically stable and able to tolerate the changes in position that are routinely conducted as part of the standard of care in the medical ICU.
  • •Patient should be able to provide informed consent to the study. Any participant speaking any language will be offered participation.
  • •Able to actively participate in Assisted Manual Pronation Therapy per nursing assessment.

排除标准

  • •Contraindication for prone positioning:
  • •Intracranial pressure >30 mm Hg or cerebral perfusion pressure <60 mmHg
  • •Massive hemoptysis requiring an immediate surgical or interventional radiology procedure
  • •Tracheal surgery or sternotomy during the previous 15 days
  • •Serious facial trauma or facial surgery during the previous 15 days
  • •Deep venous thrombosis treated for less than 2 days
  • •Cardiac pacemaker inserted in the last 2 days
  • •Unstable spine, femur, or pelvic fractures
  • •Hemodynamic instability or severe cardiac arrhythmia (chronic AFib is not a contraindication). Mean arterial pressure lower than 60 mm Hg, >1 vasopressor agent or Norepinephrine equivalent dose >0.06 mcg/kg/min
  • •Pregnant women
  • •Single anterior chest tube with air leaks
  • •Burns on more than 20 % of the body surface
  • •Delirium or altered mental status increasing fall risk while in prone position.
  • •End-of-life decision before inclusion
  • •Subject deprived of freedom, minor, subject under a legal protective measure
  • •Unable to actively participate in Assisted Manual Pronation Therapy per nursing assessment
  • •Lacking capacity to provide informed consent.
  • •Individuals with mechanical or vascular disease precluding safe displacement of the head, for example: cervical spinal fusion, limited range of motion, or severe vascular occlusive disease of the head and neck.
  • •Body mass index (BMI) greater than 70 kg/m2, or unable to actively participate in Assisted Manual Pronation Therapy per nursing assessment at any BMI value.

研究组 & 干预措施

HFNC and NIPPV

Experimental

Combined use of prone positioning and non-invasive positive pressure ventilation (NIPPV) and high-flow nasal cannula (HFNC)

干预措施: Body position change (Other)

结局指标

主要结局

Rate of intubation

时间窗: 1 year

Number of critically ill patients with acute hypoxemic and/or hypercapnic respiratory failure, secondary to COVID-19 infection to require intubation and mechanical ventilation

次要结局

  • Incidence of hypotension and cardiac arrhythmias and other nursing-related risks of combining prone positioning with high-flow nasal cannula and non-invasive positive pressure ventilation(1 year)

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Gustavo A. Cortes Puentes

Principal Investigator

Mayo Clinic

研究点 (1)

Loading locations...

相似试验

Use of Combined Prone Positioning and High-Flow... | 临床试验